NCT04061304

Brief Summary

This is a pilot study to test the efficacy of repetitive transcranial magnetic stimulation (rTMS) in treating individuals with Anorexia Nervosa and Bulimia Nervosa. The main objective of this study is to determine the short and long-term efficacy of repetitive transcranial magnetic stimulation (rTMS) in reducing eating disorder symptoms (i.e. binging, purging, restricting, intense fear of gaining wait, etc;) in Anorexia Nervosa and Bulimia Nervosa. The investigators will also be comparing the brain activity patterns of individuals with Anorexia Nervosa and Bulimia Nervosa to healthy controls using electroencephalography (EEG). Further, the investigators would like to examine if the activation patterns in these patients change after receiving rTMS.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2020

Shorter than P25 for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 19, 2019

Completed
10 months until next milestone

Study Start

First participant enrolled

June 1, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 19, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 19, 2021

Completed
Last Updated

October 8, 2021

Status Verified

March 1, 2021

Enrollment Period

10 months

First QC Date

July 2, 2019

Last Update Submit

October 1, 2021

Conditions

Keywords

rTMS

Outcome Measures

Primary Outcomes (1)

  • Weekly Binge/Purge Frequency on Eating Disorder Examination

    Outcome measured by change of binge/purge episodes from baseline to the end of treatment. If the participant has a final score of 0 binges and 0 purges they will be considered in remission. A 50% improvement will be defined as a response to the rTMS.

    baseline, after week 1, week 2, and week 3 of treatment, 3 months post treatment, and 6 months post treatment.

Secondary Outcomes (2)

  • Change in Beck Anxiety Inventory (BAI)

    baseline, after week 1, week 2, and week 3 of treatment, 3 months post treatment, and 6 months post treatment.

  • Change in Beck Depression Inventory (BDI)

    baseline, after week 1, week 2, and week 3 of treatment, 3 months post treatment, and 6 months post treatment.

Study Arms (4)

Active rTMS (Anorexia Nervosa)

EXPERIMENTAL

Patients in this arm will receive 40 sessions of active rTMS. Every day, the first session of rTMS for both groups will be applied to the left DLPFC using intermittent Theta Burst Stimulation (iTBS). For the second session each day the patients in the anorexia group will receive low-frequency treatment (1 Hz, 60 second cycles, 30 second inter-train interval, 20 trains, 1200 total pulses) at 120% of the resting motor threshold to the orbitofrontal cortex

Device: Repetitive Transcranial Magnetic Stimulation

Active rTMS (Bulimia Nervosa)

EXPERIMENTAL

Patients in this arm will receive 40 sessions of active rTMS. Every day, the first session of rTMS for both groups will be applied to the left DLPFC using intermittent Theta Burst Stimulation (iTBS). For the second session each day the patients in the bulimia group will receive high-frequency (10 Hz, 5 second cycles, 50 pulses, 25 second inter-train interval, 60 trains, 3000 total) at 120% of the resting motor threshold treatment to the left dorsomedial prefrontal cortex

Device: Repetitive Transcranial Magnetic Stimulation

Sham rTMS (Anorexia Nervosa)

SHAM COMPARATOR

Patients in this arm will receive 40 sessions of sham rTMS. They will be set up the same as the active Anorexia Nervosa group however their will be no actual brain stimulation.

Device: Sham Transcranial Magnetic Stimulation

Sham rTMS (Bulimia Nervosa)

SHAM COMPARATOR

Patients in this arm will receive 40 sessions of sham rTMS. They will be set up the same as the active Bulimia Nervosa group however their will be no actual brain stimulation.

Device: Sham Transcranial Magnetic Stimulation

Interventions

A non-invasive method of brain stimulation.

Active rTMS (Anorexia Nervosa)Active rTMS (Bulimia Nervosa)

A device designed to look, sound, and feel like a real magnetic stimulation coil without actually stimulating the brain.

Sham rTMS (Anorexia Nervosa)Sham rTMS (Bulimia Nervosa)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Confirmed diagnosis of Anorexia Nervosa or Bulimia Nervosa, must pass rTMS screening questionnaire

You may not qualify if:

  • Diagnosis of another psychiatric disorder, except MDD.
  • Any rTMS counter-indications:
  • History of seizures
  • Metal in head
  • Currently pregnant
  • Having received rTMS for any reason in the past as this would interfere with participant blinding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Feeding and Eating DisordersAnorexia NervosaBulimia Nervosa

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Study Officials

  • Mandana Modirrousta, MD PhD FRCPC

    University of Manitoba

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 2, 2019

First Posted

August 19, 2019

Study Start

June 1, 2020

Primary Completion

March 19, 2021

Study Completion

March 19, 2021

Last Updated

October 8, 2021

Record last verified: 2021-03